Indeed, analysis of the TCGA cutaneous melanoma dataset revealed that BRD4 and TCF19 were positively associated in melanoma and that the levels of TCF19 inversely correlated with patient's survival (P = 8.3 × 10−3; Fig 5F and Appendix Fig S8). Here, BRD4 is linked to cutaneous melanoma.